Skip to content

Public FDA record

Z-0025-2020: Monarch, Aspirating Biopsy Needle, REF: MBR-000012, Rx Only, UDI: B634MBR0000120

Recall record Z-0025-2020 for AURIS HEALTH INC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0025-2020
Company in FDA record
AURIS HEALTH INC
FDA record creation date
Nov 16, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Reports of aspirating biopsy needle breakage

Source facts

Action
On 04/19/19, Urgent Medical Device Notifications were mailed to customers. Customers were advised the following: Please review the updated instructions for use for proper insertion, along with updated and warnings/cautions related to the use of the device. Specifically, the following instructions were included: " Do NOT use excessive insertion force if resistance is encountered during insertion of the needle through the bronchoscope working channel. Excessive force may cause damage to either the device or the bronchoscope working channel. " DO inspect the needle sharp for damage prior to use. If damage is found, do not use the needle. " Do NOT use the needle if the bronchoscope working channel is damaged, kinked or compromised. Please ensure that all necessary personnel in your facility are made aware of this notification, and please maintain awareness on this notice to ensure effectiveness of the corrective action. Complete and return the Acknowledgement Form. Customers with questions are encouraged to call 1-800-434-0032. On 06/25/19, Urgent Medical Device Recall (Removal) notices were mailed to customers informing them that the recalling firm is in the process of investigating the root cause and they will contact customers when replacement product becomes available. In the meantime, refer to the Compatibility Statement in the User Manual when deciding to use other commercially available needles. Customers were advised: 1.Examine your inventory immediately to determine if you have product lots subject to this recall (removal) on hand and quarantine such product(s). 2. Remove the product lots subject to this recall (removal) and communicate the issue to relevant personnel, or anyone else in your facility who needs to be informed. 3. If any product lots subject to this recall (removal) has been forwarded to another facility, contact that facility to arrange return. 4. Complete the attached Acknowledgement Form confirming receipt of this notice an
Initiated
2019-04-19
Root cause
Labeling design
Terminated
2022-01-19
Distribution
US nationwide distribution to the states of: CT, FL, MI, OK, TN, MS, CA, MN, OH, PA, and IL.
Recall number
Z-0025-2020
Recall status
Terminated
CDRH record ID
172660
FDA record created
2019-11-16
Recall event number
82763

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗